Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.

Source:http://linkedlifedata.com/resource/pubmed/id/19086995

Download in:

View as

General Info

PMID
19086995